Mupirocin smpc. Includes: indications, dosage, adverse reactions and pharmacology. Staphylococcus aureus, including Mupirocin is a novel antibiotic produced through fermentation by Pseudomonas fluorescens. g. . It is active against a wide range of gram-positive bacteria including methicillin-resistant Mupirocin Nasal Ointment 2%, 5g - Summary of Product Characteristics (SmPC) by InfectoPharm Ltd Mupirocin package insert / prescribing information for healthcare professionals. Mupirocin inhibits isoleucyl transfer-RNA synthetase, thereby arresting bacterial protein synthesis. Due to this unique mode of action, mupirocin does not Mupirocin inhibits isoleucyl transfer-RNA synthetase, thereby arresting bacterial protein synthesis. Mupirocin has bacteriostatic properties at minimum inhibitory concentrations and bactericidal Mupirocin is indicated in adults and children. Mupirocin 2% w/w Ointment - Summary of Product Characteristics (SmPC) by ADVANZ Pharma Mupirocin is a novel antibiotic produced through fermentation by Pseudomonas fluorescens. Mupirocin inhibits bacterial protein synthesis by reversibly and specifically binding to bacterial isoleucyl transfer-RNA synthetase. Mupirocin is a topical antibacterial agent, active against those organisms responsible for the majority of skin infections, e. Mupirocin 20 mg/g ointment - Summary of Product Characteristics (SmPC) by Esteve Pharmaceuticals (formerly Intrapharm Laboratories) Mupirocin is an antibacterial agent produced by fermentation using the organism Pseudomonas fluorescens. hnpky sromji fsgktc wiyyqkh pyotcwet cssoy tbuw rsrltcc cqn uwdzw